Puyod, Agripino B.

HRN: 27-22-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2025
CEFTAZIDIME 1GM (VIAL)
06/08/2025
06/14/2025
IV
500mg
Q24
Cap-hr
Checking Initial Appropriateness 

 Indication:  Empiric Then Culture-directed    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines